Trombly Business Law
                                                   1320 Centre Street, Suite 202
                                                                Newton, MA 02429
                                                        Telephone (617) 243-0060
                                                        Facsimile (309) 406-1426

Amy  M.  Trombly,  Esq.
amy@tromblybusinesslaw.com

December  15,  2006

Delivered  by  electronic  submission  via  EDGAR

United  States  Securities  and  Exchange  Commission
Division  of  Corporation  Finance
100  F  Street,  N.E.,  Mail  Stop  7010
Washington,  DC  20549

     Attn:     Mr.  Brian  V.  McAlllister

     Re:     FTS  Group,  Inc.
          Item  4.02  Form  8-K
          Filed  December  7,  2006
          File  No.  0-24829


Dear  Mr.  McAllister:

I  am  securities  counsel  for  FTS Group, Inc. (the "Company").  I enclose for
filing  under  the Securities Act of 1933, as amended, an amended Form 8-K, File
No.  0-24829,  together  with  certain  exhibits  thereto  (the  "Form  8-K").

The Amendment to the Form 8-K contains revisions that have been made in response
to  comments  received  from the staff of the Securities and Exchange Commission
(the  "Staff")  in  their  letter  dated  December  11,  2006.

Set  forth  below  are  the  Company's  responses  to the Staff's comments.  The
numbering  of  the  responses  corresponds  to  the numbering of comments in the
letter  from  the  Staff.

Form  8-K  filed  December  7,  2006
- ------------------------------------

Comment  1.     Please  provide us with a preliminary summary that supports your
basis  for stating the measurement of warrants classified as liabilities to fair
value  will  not  have  any  impact  on earnings in any of the amended financial
statements.  Please include a detailed discussion of the facts and circumstances
as  well  as the applicable authoritative accounting guidance that supports your
conclusion.

Response  1.  The Company reviewed numerous authoritative accounting guidance in
determining  proper  measurement  and  classification  issues  surrounding  the
warrants  from  the  December  29,  2005  financing.  We  concluded  that  the
reclassification  of  the  warrants  from  equity  to liability would not impact
earnings  in  the  subsequent  quarters  for  two  main  reasons.

Firstly, EITF-0019 referred us to SFAS No. 133 to determine if the warrants were
derivative  in nature. Based on a thorough review of the subscription agreements
and the specific criteria in paragraph six of the SFAS 133 we concluded that the
warrants  were  not  derivatives.

Secondly,  we  reviewed  EITF  98-5  Accounting  for Convertible Securities with
Beneficial  Conversion  Features  or  Contingently Adjustable Conversion Ratios.
Paragraph  13  of  this  abstract  states  "The  Task  Force  also discussed the
accounting  for (a) a security that becomes convertible only upon the occurrence
of  a  future event outside the control of the holder and (b) a security that is
convertible  from  inception  but contains conversion terms that change upon the
occurrence  of  a  future  event.  The  Task  Force reached a consensus that any
contingent  beneficial  conversion  feature should be measured at the commitment
date  but  not  recognized  in  earnings  until  the  contingency  is  resolved.

The  Company  concluded  that  the  pending  authorization  of  an  increase  in
authorized  shares  sufficient  to  cover  all possible future conversions, is a
contingency  that  fits  the  paragraph  13  (a).  In addition, the Subscription
agreement  that  governs  this Issue precludes exercise of warrants in excess of
authorized  shares.  Per  paragraph  9  (r)  of  the  Agreement, subscribers are
permitted  to  exercise warrants only up to their pro-rata portion not exceeding
available  authorized  shares.  The  entire  paragraph  is  replicated  below.

(r)     Shareholder Approval.   The Company and Subscribers agree that until the
        --------------------
Company  obtains  shareholder  approval  of an increase in the authorized Common
Stock of the Company to not less than _________ Shares of Common Stock, files an
amendment  to  the Company's Articles of Incorporation and reserves ____% of the
amount of shares of Common Stock necessary to allow the conversion of the entire
Note principal and interest that may accrue thereon and 100% of the Common Stock
issuable  upon  exercise  of  all of the Warrants issued in connection with this
Agreement  (collectively  such shares of Common Stock being the "RESERVE AMOUNT"
and  the  shareholder  approval,  amendment  and  reservation  being  the
"RESERVATION"),  each  Subscriber  may  not  convert  the  Note nor exercise any
Warrants in excess of each Subscriber's pro rata portion of __________ shares of
Common Stock.  Each Subscriber's pro rata portion is equal to the Note principal
purchased by such Subscriber divided by the aggregate Note principal sold in the
Offering.  The Company undertakes to file a preliminary proxy statement with the
Commission  for  a  meeting  of  the  Company's  shareholders  relating  to  the
Reservation  not  later than ten (10) days after the Closing Date ("PROXY FILING
DATE").   The  Company  covenants  to  use  its  best  efforts  to  obtain  the
Reservation  not  later  than  fifty  (50)  days  after  the  Closing

Conclusion:  The  liability will remain at its original measurement amount until
future  events  occur.


Comment 2.     Please amend to delete the phrase "the SEC has taken the position
that  we  still need to reclassify the treatment of the warrants" from the press
release in your Item 4.02 Form 8-K.  The decision to include the restatements in
the  2005 Form 10-KSB and Form 10-QSB for the three months ended March 31, 2006,
June  30,  206  and  September  30,  2006,  is  management's  decision.

Response  2.     The  Company  has  complied  with  the  Staff's  comment.

Comment  3.     When  you  amend  your  periodic  reports  to file your restated
financial  statements,  describe  the effect of the restatement on the officers'
conclusions regarding the effectiveness of the company's disclosure controls and
procedures.  See  Item 307 of Regulation S-B.  If the officers conclude that the
disclosure  controls  and  procedures  were  effective, despite the restatement,
describe  the  basis  for  the  officers'  conclusions,  as  applicable.

Response  3.     The  Company  has  complied  with  the  Staff's  comment.



If  you  have further questions or comments, please feel free to contact us.  We
are  happy  to  cooperate  in  any  way  we  can.

                              Regards,

                              /s/  Amy  M.  Trombly
                              ---------------------
                              Amy  M.  Trombly
                              Counsel  for  FTS  Group,  Inc.

cc:     FTS  Group,  Inc.